Delivery Order SPE2DR25D2005-SPE2DR26FF2K3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,297.06 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on June 27, 2025, with completion scheduled for June 30, 2025. This firm fixed price, competitively awarded delivery order represents a pharmaceutical supply requirement without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the place of...
- The Defense Logistics Agency awarded a delivery order valued at $30,717.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (quantity 90) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a $105,814.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) with an ultimate completion date of January 23, 2026. This contract was awarded on a non-set-aside, competitive basis to the Conshohocken, Pennsylvania-based pharmaceutical distributor, a subsidiary of parent company Cencora, Inc. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,879.86 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on January 28, 2026, with an ultimate completion date of January 29, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under the company's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,078.93 on January 20, 2026, to supply Jardiance 25 mg tablets (90-count) to the Defense Logistics Agency with an ultimate completion date of January 21, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $9,616.38 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count supply) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price, non-set-aside contract is being performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent organization, Cencora, Inc., which holds a significant...
- The Defense Logistics Agency awarded a delivery order valued at $6,346.46 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 29, 2026, with an ultimate completion date of January 30, 2026. This firm fixed-price, non-set-aside contract was performed at the awardee's location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $11,937.78 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 20, 2026, with an ultimate completion date of January 21, 2026. This is a firm fixed-price, non-set-aside contract performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $18,522.20 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on January 28, 2026, with completion expected by January 29, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,363.36 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 22, 2026, and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving critical federal medical...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FF2K3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,436.31 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count package) on February 4, 2026, with an ultimate completion date of February 5, 2026. This firm fixed-price, non-set-aside contract is being performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the comprehensive vehicle for pharmaceutical and medical supply distribution to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that supplies a broad range of brand-name and generic medications, vaccines, and medical devices to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for the diabetes medication Jardiance represents a routine pharmaceutical procurement typical of the company's extensive portfolio of competitively awarded contracts with DLA, demonstrating its critical role in supplying essential prescription medications to military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 2/3/26 |